Pfizer (BSP:PFIZ34) E10: R$3.63 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:PFIZ34 Pfizer Inc BSP:PFIZ34
68 GF Score
Price R$33.94
GF Value R$33.58
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Pfizer E10?

Pfizer BSP:PFIZ34 +2.14% 68 E10 is R$3.63 as of Jun. 2026. GuruFocus rates BSP:PFIZ34 with a GF Score™ of 68/100 and a GF Value™ of R$33.58 (Fairly Valued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Pfizer's adjusted earnings per share data for the three months ended in Jun. 2026 was R$-0.051. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is R$3.63 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Pfizer's average E10 Growth Rate was 0.70% per year. During the past 3 years, the average E10 Growth Rate was -2.00% per year. During the past 5 years, the average E10 Growth Rate was 4.40% per year. During the past 10 years, the average E10 Growth Rate was 6.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Pfizer was 20.10% per year. The lowest was -4.10% per year. And the median was 8.30% per year.

As of today (2026-08-08), Pfizer's current stock price is R$33.94. Pfizer's E10 for the quarter that ended in Jun. 2026 was R$3.63. Pfizer's Shiller PE Ratio of today is 9.35.

During the past 13 years, the highest Shiller PE Ratio of Pfizer was 24.28. The lowest was 7.88. And the median was 16.93.


Pfizer  (BSP:PFIZ34) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Pfizer's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=33.94/3.63
=9.35

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Pfizer was 24.28. The lowest was 7.88. And the median was 16.93.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Pfizer E10 Related Terms


Pfizer E10 Historical Data

* Premium members only.

The historical data trend for Pfizer's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pfizer E10 Chart

Pfizer Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.49 3.94 3.28 4.25 3.89

Pfizer Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.80 3.76 3.89 3.66 3.63

BSP:PFIZ34 vs BMY, GILD, AMGN: E10 Comparison

For the Drug Manufacturers - General subindustry, Pfizer's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pfizer Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pfizer's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Pfizer's Shiller PE Ratio falls into.


BSP:PFIZ34
68GF Score
Pfizer Inc BSP:PFIZ34
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pfizer E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Pfizer's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=-0.051/333.9520*333.9520
=-0.051

Current CPI (Jun. 2026) = 333.9520.

Pfizer Quarterly Data

per share eps CPI Adj_EPS
201609 0.179 241.428 0.248
201612 0.109 241.432 0.151
201703 0.399 243.801 0.547
201706 0.420 244.955 0.573
201709 0.368 246.819 0.498
201712 1.664 246.524 2.254
201803 0.484 249.554 0.648
201806 0.613 251.989 0.812
201809 0.709 252.439 0.938
201812 -0.068 251.233 -0.090
201903 0.653 254.202 0.858
201906 0.858 256.143 1.119
201909 1.401 256.759 1.822
201912 -0.062 256.974 -0.081
202003 0.733 258.115 0.948
202006 0.804 257.797 1.042
202009 0.351 260.280 0.450
202012 0.129 260.474 0.165
202103 1.212 264.877 1.528
202106 1.232 271.696 1.514
202109 1.874 274.310 2.281
202112 0.834 278.802 0.999
202203 1.704 287.504 1.979
202206 2.183 296.311 2.460
202209 1.979 296.808 2.227
202212 1.141 296.797 1.284
202303 1.263 301.836 1.397
202306 0.498 305.109 0.545
202309 -0.519 307.789 -0.563
202312 -0.735 306.746 -0.800
202403 0.685 312.332 0.732
202406 0.013 314.175 0.014
202409 1.080 315.301 1.144
202412 0.107 315.605 0.113
202503 0.749 319.799 0.782
202506 0.707 322.561 0.732
202509 0.831 324.800 0.854
202512 -0.396 324.054 -0.408
202603 0.614 330.213 0.621
202606 -0.051 333.952 -0.051

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of R$3.63 mean?
Pfizer (BSP:PFIZ34) has a E10 of R$3.63 as of Jun. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Pfizer and its competitors.
Is Pfizer's E10 too high?
Pfizer's current E10 is R$3.63. Overall, Pfizer has a GF Score™ of 68/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Pfizer's E10 compare to BMY and GILD?
Pfizer's E10 of R$3.63 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Pfizer and its competitors. Pfizer's current E10 is R$3.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pfizer stock overvalued right now?
Based on GuruFocus' analysis, Pfizer (BSP:PFIZ34) is currently considered Fairly Valued. The stock's GF Value™ is R$33.58, compared to a current price of R$33.94 — trading 1.1% above its estimated fair value. The current E10 is R$3.63. Pfizer's overall GF Score™ is 68/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Pfizer (BSP:PFIZ34), the current E10 is R$3.63 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pfizer (BSP:PFIZ34) Overvalued in 2026?

Based on GuruFocus' analysis, Pfizer stock appears to be overvalued. The current stock price of R$33.94 is trading 1.1% above its estimated GF Value™ of R$33.58. GuruFocus considers Pfizer to be Fairly Valued.

Key valuation signals for BSP:PFIZ34:

  • E10: R$3.63
  • GF Value™: R$33.58 vs. price of R$33.94 (1.1% above fair value)
  • GF Score™: 68/100 with 6 warning signs

No single metric tells the full story. See the BSP:PFIZ34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Pfizer Business Description

Address 66 Hudson Boulevard East, New York, NY, USA, 10001-2192
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
68GF Score

Get the complete analysis for BSP:PFIZ34

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$33.94
Price
R$33.58
GF Value